机构:[1]Department of Neurology, Shenzhen People’s Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, 518020, PR China深圳市康宁医院深圳市人民医院深圳医学信息中心中国医科大学附属盛京医院中国医科大学盛京医院[2]Center of Clinical Research, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi, 214023, PR China[3]Department of Neurology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, 200434, PR China[4]Department of Neurology, Yancheng First People’s Hospital, Yancheng, 224001, PR China[5]University of Traditional Chinese Medicine, Kunming, 650500, PR China[6]Otolaryngological Department, Yunnan Province Traditional Chinese Medicine, Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, 650500, PR China
Natural Science Foundation of China (NFSC) grant (81671219, 82071364, 81760881, 81901259), Natural Science Foundation of Jiangsu Province (BK20180168), Medical Young Talents Program of Jiangsu Province (QNRC2016191), Shenzhen Special Fund for Basic Research (Shenzhen Natural Science Foundation, JCYJ20190806145812589), and Top Talent Support Program for young and middle-aged people of Wuxi Health Committee (HB2020016, HB2020015).
第一作者机构:[1]Department of Neurology, Shenzhen People’s Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, 518020, PR China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Li Zai-Wang,Zhao Jing-Jing,Li Su-Ya,et al.Blocking the EGFR/p38/NF-κB signaling pathway alleviates disruption of BSCB and subsequent inflammation after spinal cord injury.[J].NEUROCHEMISTRY INTERNATIONAL.2021,150:doi:10.1016/j.neuint.2021.105190.
APA:
Li Zai-Wang,Zhao Jing-Jing,Li Su-Ya,Cao Ting-Ting,Wang Yi...&Xi Guang-Jun.(2021).Blocking the EGFR/p38/NF-κB signaling pathway alleviates disruption of BSCB and subsequent inflammation after spinal cord injury..NEUROCHEMISTRY INTERNATIONAL,150,
MLA:
Li Zai-Wang,et al."Blocking the EGFR/p38/NF-κB signaling pathway alleviates disruption of BSCB and subsequent inflammation after spinal cord injury.".NEUROCHEMISTRY INTERNATIONAL 150.(2021)